pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
pre_registration
fuzuloparib
fuzuloparib [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Jiangsu Hengrui Pharmaceuticals Co Ltd
1 catalysts
Phase 2
navlimetostat
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
1 catalysts
Marketed
olaparib
Lynparza (olaparib)
Epithelial Ovarian Cancer
AstraZeneca Pharmaceuticals LP
1 catalysts
Phase 3
← prev
page 2 of 62
next →
131
Pain89
Neurology1
raludotatug deruxtecan
Adenocarcinoma Of The Gastroesophageal Junction
Daiichi Sankyo Co Ltd
1 catalysts
Phase 2
samuraciclib
samuraciclib [INN]
Breast Cancer
Carrick Therapeutics Ltd
1 catalysts
Phase 3
serplulimab
Small-Cell Lung Cancer
Programmed cell death protein 1
Shanghai Henlius Biotech Inc
1 catalysts
Phase 2
soficabtagene geleucel
soficabtagene geleucel [INN]
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Wugen Inc
1 catalysts
Phase 3
soquelitinib
Peripheral T-Cell Lymphomas (PTCL)
$CRVSCorvus Pharmaceuticals, Inc.
1 catalysts
Phase 2
toripalimab
Loqtorzi (toripalimab-tpzi)
Esophageal Squamous Cell Carcinoma (ESCC)
Programmed cell death protein 1
$CHRSCoherus Oncology, Inc.
1 catalysts
Phase 3
tremelimumab
Imjudo (tremelimumab-actl)
Small-Cell Lung Cancer
Cytotoxic T-lymphocyte protein 4
$AZNASTRAZENECA PLC
1 catalysts
Phase 2
ubidecarenone
ubidecarenone [INN]
Metastatic Adenocarcinoma of The Pancreas
BPGbio Inc
1 catalysts
Marketed
goserelin LA
Zoladex (goserelin)
Metrorrhagia (Abnormal Uterine Bleeding)
TerSera Therapeutics LLC
76 catalysts
Marketed
(daratumumab + hyaluronidase (human recombinant))
Darzalex Faspro ((daratumumab + hyaluronidase (human recombinant)-fihj))
Multiple Myeloma (Kahler Disease)
Janssen Biotech Inc
16 catalysts
Marketed
retifanlimab
Zynyz (retifanlimab-dlwr)
Squamous Non-Small Cell Lung Cancer
Programmed cell death protein 1
$INCYINCYTE CORP
6 catalysts
pre_registration
durvalumab
Imfinzi (durvalumab)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Programmed cell death 1 ligand 1
$AZNASTRAZENECA PLC
2 catalysts
Marketed
Jelmyto
Jelmyto (mitomycin)
Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
$URGNUroGen Pharma Ltd.
1 catalysts
Marketed
Efudex
Efudex (fluorouracil)
Basal Cell Carcinoma (Basal Cell Epithelioma)
Extrovis AG
42 catalysts
Phase 1
RP-72
Metastatic Pancreatic Cancer
Rise Biopharmaceutical Ltd
1 catalysts
Marketed
elranatamab
Elrexfio (elranatamab-bcmm)
Refractory Multiple Myeloma
T cell surface glycoprotein CD3Tumor necrosis factor receptor superfamily member 17
$PFEPFIZER INC
8 catalysts
Phase 1
EBTATE
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Molecular Targeting Technologies Inc
1 catalysts
Phase 3
berubicin hydrochloride
Recurrent Glioblastoma Multiforme (GBM)
DNA topoisomerase II
$CNSPCNS Pharmaceuticals, Inc.
1 catalysts
Marketed
busulfan
Myleran (busulfan)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Woodward Pharma Services LLC
1 catalysts
Marketed
denosumab
Prolia (denosumab)
Glucocorticoid-Induced Osteoporosis
$AMGNAMGEN INC
1 catalysts
Marketed
fruquintinib
Fruzaqla (fruquintinib)
Metastatic Colorectal Cancer
Takeda Pharmaceuticals USA Inc
1 catalysts
pre_registration
sacituzumab govitecan
Trodelvy (sacituzumab govitecan)
Triple-Negative Breast Cancer (TNBC)
Tumor-associated calcium signal transducer 2DNA topoisomerase 1
$GILDGILEAD SCIENCES, INC.
1 catalysts
pre_registration
apatinib mesylate
CAM-RIVO (apatinib mesylate)
Hepatocellular Carcinoma
Vascular endothelial growth factor receptor 2
Elevar Therapeutics Inc
1 catalysts
pre_registration
iberdomide hydrochloride
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
1 catalysts
Marketed
zanubrutinib
Brukinsa (zanubrutinib)
Membranous Glomerulonephritis
Tyrosine-protein kinase BTK
$ONCBeOne Medicines Ltd.
1 catalysts
Phase 3
HLX-43
Squamous Non-Small Cell Lung Cancer
Shanghai Henlius Biotech Inc
1 catalysts
Phase 2
dostarlimab
Jemperli (dostarlimab-gxly)
Rectal Cancer
Programmed cell death protein 1
$GSKGSK plc
1 catalysts